Mode
Text Size
Log in / Sign up
Phase 4 Completed N=278 Randomized Treatment

Informing Tobacco Treatment Guidelines for African American Non-Daily Smokers

Source: ClinicalTrials.gov NCT02244918 ↗
Enrolled (actual)
278
Serious AEs
0.0%
Results posted
Jan 2019
Primary outcomePrimary: Smoking Abstinence — 21; 8 Participants
◆ Published Evidence
Emerging
4citations · ~1 / year
A randomized clinical trial of counseling and nicotine replacement therapy for treatment of African American non-daily smokers: Design, accrual, and baseline characteristics.
Contemporary clinical trials · 2018 · Open access · Likely link

Summary

The researchers are testing if counseling alone or counseling plus over-the-counter nicotine replacement therapies (NRT), like the patch,gum, or lozenge, helps African American non-daily smokers quit smoking.

Linked Publications

  • A randomized clinical trial of counseling and nicotine replacement therapy for treatment of African American non-daily smokers: Design, accrual, and baseline characteristics.
    Contemporary clinical trials · 2018 · 4 citations · Open access · Likely link

Outcome Measures

OutcomeResultp-value
PRIMARY
Smoking Abstinence
13; 6
SECONDARY
Smoking Abstinence
13; 6
SECONDARY
Concentration of Urinary Cotinine
1538.3; 1905.3; 1513.2; 1649.3
SECONDARY
Urinary Concentration of NNAL (4-(Methyl Nitrosamine)-1-(3-pyridyl)-1-butanol)
100.9; 97.1; 47.6; 49.3
SECONDARY
Total Days Abstinent
10.3; 10.4; 17.4; 12.8; 20.8; 19.8
SECONDARY
Cigarettes Used
100.4; 85.8; 43.2; 57.9; 30.9; 53.3

Eligibility Criteria

Inclusion Criteria

  • African American adults who are interested in quitting and whose smoking patterns meet criteria for non-daily smoking as determined by eligibility screening

Exclusion Criteria

  • Contraindications to behavioral counseling, nicotine gum, patch, or lozenge and unable to complete study procedures as determined by eligibility screening
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02244918) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search